Maria Katsarou advises pharmaceutical and biotechnology companies on early commercialization strategy, helping shape the critical decisions that define product and portfolio success.
She partners with clients to evaluate business development and licensing opportunities, prioritize indications, and design integrated development, access, and go-to-market strategies that bridge R&D and commercial objectives. Her experience spans oncology, autoimmune diseases, and vaccines, with deep expertise in advanced therapy medicinal products (ATMPs).
Before joining Avalere, Maria conducted research in molecular biology and genetics, strengthening her ability to connect scientific innovation with patient and market needs.
Maria holds an MSc in Cell and Gene Therapy from University College London and a BSc in Biology from the University of Thessaloniki. She speaks English, Greek, Spanish, and French.